Inflammatory bowel disease related osteonecrosis: Report of a large series with a review of the literature

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2005, Pages 243-249

  Klingenstein, G ^a,b   Levy, R N ^a   Kornbluth, A ^a   Shah, A K ^a   Present, D H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b c/o Daniel H Present MD ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CIPROFLOXACIN; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; ROFECOXIB; SALAZOSULFAPYRIDINE; TACROLIMUS; VANCOMYCIN;

ACCURACY; ADULT; AGED; ASSOCIATION RESEARCH CIRCULATION OSSEOUS SCORING SYSTEM; BONE NECROSIS; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; ENCEPHALITIS; ENTERITIS; FEMALE; HIP DISEASE; HUMAN; JOINT PROSTHESIS; KNEE DISEASE; KNEE PAIN; LISTERIA MONOCYTOGENES; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROCTITIS; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SHOULDER; ULCERATIVE COLITIS;

ADULT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OSTEONECROSIS; PREDNISONE; TIME FACTORS;

EID: 14044268803     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02231.x     Document Type: Review

References (25)

1. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995; 77: 459-74.
2. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326: 1473-9.
3. Coventry MB, Beckenbaugh RD, Nolan DR, Ilstrup DM. 2,012 Total hip arthroplasties. A study of postoperative course and early complications. J Bone Joint Surg Am 1974; 56: 273-84.
4. Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications: 1. Tissue biology. Clin Orthop 1979; 138: 284-309.
5. Johanson NA. Musculoskeletal problems in hemoglobinopathy. Orthop Clin North Am 1990; 21: 191-8.
6. Hermann G, Goldblatt J, Levy RN, Goldsmith SJ, Desnick RJ, Grabowski GA. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am J Roentgenol 1986; 147: 943-8.
7. Jacobs B. Alcoholism-induced bone necrosis. N Y State J Med 1992; 92: 334-8.
8. Jones LC, Mont MA, Le TB et al. Procoagulants and osteonecrosis. J Rheumatol 2003; 30: 783.
9. Chryssanthou CP. Dysbaric osteonecrosis. Etiological and pathogenetic concepts. Clin Orthop 1978; 130: 94-106.
10. Fishel B, Caspi D, Eventov I, Avrahami E, Yaron M. Multiple osteonecrotic lesions in systemic lupus erythematosus. J Rheumatol 1987; 14: 601-4.
11. Cruess RL. Steroid-induced osteonecrosis: a review. Can J Surg 1981; 24: 567-71.
12. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 1985; 79: 596-604.
13. Vakil N, Sparberg M. Steroid-related osteonecrosis in inflammatory bowel disease. Gastroenterology 1989; 96: 62-7.
14. Brom B, Bank S, Marks IN, Cobb JJ. Periostitis, aseptic necrosis, and arthritis occurring in a patient with Crohn's disease. Gastroenterology 1971; 60: 1106-9.
15. Gardeniers JM. ARCO international classification of osteonecrosis. ARCO Newsletter 1993; 5: 79-82.
16. Freeman HJ, Freeman KJ. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. Can J Gastroenterol 2000; 14: 138-43.
17. Jones JP Jr. Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. In: Urbaniak, JR, Jones, JP Jr, eds. Osteonecrosis: Etiology, Diagnosis, and Treatment, 1st edn. Rosemount, IL: American Academy of Orthopaedic Surgeons, 1997.
18. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61: 140-5.
19. Souto JC, Martinez E, Roca M et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40: 1883-9.
20. Freeman HJ, Kwan WC. Brief report: non-corticosteroid-associated osteonecrosis of the femoral heads in two patients with inflammatory bowel disease. N Engl J Med 1993; 329: 1314-6.
21. Khan A, Illiffe G, Houston DS, Bernstein CN. Osteonecrosis in a patient with Crohn's disease unrelated to corticosteroid use. Can J Gastroenterol 2001; 15: 765-8.
22. Collaborative Osteonecrosis Group. Symptomatic multifocal osteonecrosis. A multicenter study. Clin Orthop 1999; 369: 312-26.
23. Saito S, Saito M, Nishina T, Ohzono K, Ono K. Long-term results of total hip arthroplasty for osteonecrosis of the femoral head. A comparison with osteoarthritis. Clin Orthop 1989; 244: 198-207.
24. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop 1996; 324: 169-78.
25. Urbaniak JR, Coogan PG, Gunneson EB, Hunley JA. Treatment of osteonecrosis of the femoral head with free vascularized fibula grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am 1995; 77: 681-94.